Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$59,670,467
-$6,792,348 QoQ
Shares Held
1,096,682
-29.2% QoQ
Ownership
0.443%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#43
of 739 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $626,865,233 across 140 Biotechnology names. EXEL ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
369,451 | $230,367,476 | |
| 2 | INCY |
Incyte Corp
|
1,431,426 | $162,266,451 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
1,096,682 | $59,670,467 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
72,465 | $35,995,539 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
146,264 | $35,245,236 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
506,545 | $28,984,504 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
228,060 | $17,850,256 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
348,239 | $12,679,381 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,670,467 | 1,096,682 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $66,462,815 | 1,549,611 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $54,392,065 | 1,240,978 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $53,859,784 | 1,304,111 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $84,982,272 | 1,927,910 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,034,233 | 678,067 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,180,817 | 65,490 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,710,053 | 65,898 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,522,117 | 67,740 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,540,717 | 64,927 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,486,732 | 61,973 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $842,426 | 38,555 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,091,181 | 57,100 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $24,665,684 | 1,270,772 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $16,380,817 | 1,021,248 | Shares | Sole | 2023-02-06 | |
| 2022-06-30 | $17,198,027 | 826,034 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $217,291 | 9,585 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $2,606,271 | 142,575 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $737,130 | 34,869 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $598,891 | 32,870 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $827,110 | 36,614 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $855,744 | 42,638 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,950,083 | 79,758 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $808,916 | 34,074 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $867,578 | 50,382 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||